Methylethylamine

Methylethylamine

SCHEMBL9492386

CC(C)NC(C)C.CCNC

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylethylamine SCHEMBL18240916 0.97 TDP1 (0.53) TDP1
Diethylamine SCHEMBL871299 0.79 TP53 (0.57) TDP1
SCHEMBL28021736 0.77 TDP1 (0.67) TDP1
Dimethylamine SCHEMBL7609445 0.76 TDP1 (0.80) TDP1
Dimethylamine SCHEMBL9418117 0.76 TDP1 (0.80) TDP1
Diethylamine SCHEMBL18240909 0.76 TP53 (0.53) TDP1
Diethylamine SCHEMBL18240920 0.76 TP53 (0.53) TDP1
Methylethylamine SCHEMBL14666 0.76
SCHEMBL2020 0.76
SCHEMBL27928984 0.76 TDP1 (1.00) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5236956-A Compounds for the treatment of urinary incontinence KABI PHARMACIA AKTIEBOLAG (SE) 1993-08-17 US disclosed
EP-0367040-B1 COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE Kabi Pharmacia AB (SE) 1993-04-21 EP disclosed
EP-0367040-A1 Compounds for the treatment of urinary incontinence Kabi Pharmacia AB (SE) 1990-05-09 EP disclosed